NDC 0404-9917
Nalbuphine Hydrochloride
Nalbuphine Hydrochloride
Nalbuphine Hydrochloride is a Intramuscular; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc.. The primary component is Nalbuphine Hydrochloride.
| Product ID | 0404-9917_4b5297a9-e4da-4412-b649-ea0cc3b810f9 |
| NDC | 0404-9917 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nalbuphine Hydrochloride |
| Generic Name | Nalbuphine Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2022-01-13 |
| Marketing Category | ANDA / |
| Application Number | ANDA070918 |
| Labeler Name | Henry Schein, Inc. |
| Substance Name | NALBUPHINE HYDROCHLORIDE |
| Active Ingredient Strength | 20 mg/mL |
| Pharm Classes | Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |